Product: | 1-(5-Isoquinolinesulfonyl)piperazine DiHCl | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 11242 | ||||||||
CAS Number: | 84468-24-6 | ||||||||
Synonyms: |
HA-100 dihydrochloride; 1-(5-Isoquinolinesulfonyl)piperazine dihydrochloride |
||||||||
Pricing: |
|
||||||||
Formula: | C13H15N3O2S • 2HCl | ||||||||
Chemical Purity: | 99% | ||||||||
Molecular Weight: | 350.26 | ||||||||
Structure: | |||||||||
Appearance: | White crystalline | ||||||||
Category: | Protein Kinase Inhibitors and Activators | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Keep container tightly closed in a dry and well ventilated place. Recommended storage temperature: -20°C |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor: C. Gerard, et al.; J. Clin. Invest. 77, 61 (1986) Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives: M. Hagiwara, et al.; Mol. Pharmacol. 32, 7 (1987) |
||||||||
MSDS: | |||||||||
Description: |
Inhibitor of myosin light chain kinase, cAMP-dependent protein kinase (PKA) and PKC. |